Intro:
A second Indian vaccine maker is seeking approval for its COVID-19 vaccine.
Zydus Cadila says its 3-shot vaccine has shown 66% efficacy against the virus.
If approved, it will be the second India-made shot after Covaxin, which is already being used for mass immunisation.
Ishan Garg has more from New Delhi.
IN: Zydus says
OUT: SOC
Duration: 39 seconds